Category

news

The Importance of Data Protection and Data Integrity in Imaging Clinical Trials

The Importance of Data Protection and Data Integrity in Imaging Clinical Trials

By Paulo Rodrigues | News, Expertise, Data

QMENTA’s Key Enhancements Are Critical Enablers of Success in Clinical Studies At QMENTA, we’re on a mission to empower breakthroughs that make brain diseases a thing of the past through our...

Making a Difference in Advancing Diffusion MRI Via the MEMENTO Challenge

Making a Difference in Advancing Diffusion MRI Via the MEMENTO Challenge

By Chris M. Lindgren | News, Research use, Expertise

Diffusion MRI (dMRI) is a vital imaging technique that provides great insight into the brain microstructure. Examining these microstructural properties of the brain can not only help enrich our...

Act Now to Perform Retrospective Analysis of Past Phase II, III Alzheimer’s Clinical Trials

Act Now to Perform Retrospective Analysis of Past Phase II, III Alzheimer’s Clinical Trials

By Vesna Prchkovska | News, Expertise, Alzheimer

A Landmark FDA Approval For Alzheimer’s Shakes Up Industry On June 7th, 2021, accelerated regulatory approval was granted for Alzheimer’s drug, Aduhelm (aducanumab), designed to slow cognitive...

How COVID-19 Has Accelerated Biopharma Digital Transformation

How COVID-19 Has Accelerated Biopharma Digital Transformation

By Chris M. Lindgren | covid19news, News, Expertise

Learning From the Pandemic. There has been a massive acceleration of digitally driven innovation recently and the biopharma industry is no exception. We've witnessed incredible speed in drug...

QMENTA hosts IronTract Challenge with Harvard

QMENTA hosts IronTract Challenge with Harvard

By Paulo Rodrigues | News

QMENTA is pleased to be collaborating with Harvard’s the Athinoula A. Martinos Center for Biomedical Imaging and the University of Rochester in supporting an exciting research challenge open to image...

QMENTA receives ISO 13485:2016 certification for its QMS system

QMENTA receives ISO 13485:2016 certification for its QMS system

By Paulo Rodrigues | News

      QMENTA’s Quality Management System (QMS) is a company-wide new initiative, which has enhanced the quality of our products & services and improved our system on patient safety. We have...

QMENTA appoints Pablo Villoslada, MD, PhD Chief Medical Officer

QMENTA appoints Pablo Villoslada, MD, PhD Chief Medical Officer

By Paulo Rodrigues | News

BOSTON, MA, February 6th 2019 – QMENTA – the data-driven, AI-powered company, that aims to revolutionize the way medical imaging is used in clinical trials and clinical care – welcomes Pablo...

QMENTA to exhibit at ECTRIMS in Berlin, RSNA in Chicago & PCT in Barcelona

QMENTA to exhibit at ECTRIMS in Berlin, RSNA in Chicago & PCT in Barcelona

By Paulo Rodrigues | News

We are proud to announce that we will be exhibiting at: ECTRIMS in Berlin from October 10th to October 12th, booth C12 RSNA in Chicago from November 25th to November 30th, booth 7665 PCT in Barcelona...

QMENTA will provide Data Management and Analysis Services for Amylyx PEGASUS Clinical Trial of AMX0035 for Alzheimer’s Disease

QMENTA will provide Data Management and Analysis Services for Amylyx PEGASUS Clinical Trial of AMX0035 for Alzheimer’s Disease

By Paulo Rodrigues | News

BOSTON, MA & CAMBRIDGE, MA – QMENTA and Amylyx Pharmaceuticals today announced a collaboration to support Amylyx’s upcoming clinical trial of AMX0035 in Alzheimer’s disease. QMENTA will use its...

Award-Winning Neuroimaging Expert Bruce Rosen, MD, PhD joins QMENTA as Scientific Advisor

Award-Winning Neuroimaging Expert Bruce Rosen, MD, PhD joins QMENTA as Scientific Advisor

By Paulo Rodrigues | News

Boston: QMENTA – The innovative platform for clinical trials and research, providing an all-in-one platform that enables secure and compliant data aggregation and transfer in addition to AI-powered...